TY - JOUR T1 - 18F-DOPA PET/CT and MRI: Description of 12 Histologically-verified Pheochromocytomas JF - Anticancer Research JO - Anticancer Res SP - 791 LP - 795 VL - 34 IS - 2 AU - SILVIA MAGNALDI AU - MARIUS E. MAYERHOEFER AU - ASHKAN KHAMENEH AU - MATTHIAS SCHUETZ AU - DOMAGOJ JAVOR AU - MARKUS MITTERHAUSER AU - ROBERT DUDCZAK AU - MARCUS HACKER AU - GEORGIOS KARANIKAS Y1 - 2014/02/01 UR - http://ar.iiarjournals.org/content/34/2/791.abstract N2 - Aim: To describe the 18F-fluorodihydro-xyphenylalanine (18F-DOPA), positron emission tomography (PET) and magnetic resonance imaging (MRI) appearance of pheochromocytomas, with a focus on the presence or absence of typical MRI features. Materials and Methods: Eleven patients with histologically-verified pheochromocytoma [sporadic (n=9), multiple endocrine neoplasia (MEN) 2A syndrome (n=2)] were enrolled retrospectively. All patients underwent an MRI examination of the upper abdomen. Nine out of 11 patients underwent 18F-DOPA PET/CT, and the remaining two patients underwent independent PET and computed tomography (CT) examinations. 18F-DOPA-PET/CT examinations were considered positive when an increased tracer accumulation in the adrenal region, as shown on CT images, was observed. When an adrenal mass was detected on MRI, the T1 and T2 signal intensity and contrast enhancement pattern were recorded. Based on MR characteristics, the lesions were divided into typical and atypical. Results: Ten out of 11 patients had one lesion, while one patient had two lesions. All pheochromocytomas were detected by both PET/CT and MRI. On 18F-DOPA scans, all lesions showed an increased tracer accumulation, with a mean maximum standardized uptake value (SUVmax) of 13.7±5.75. Eight out of 12 pheochromocytomas exhibited typical MRI features, with intermediate signal intensity on T1-weighted images in-phase, absence of signal drop on T1-weighted images out-of-phase, high signal intensity on T2-weighted images, and clear contrast enhancement in the arterial phase. The remaining four lesions exhibited atypical MRI features, namely absence of one of the listed criteria. Conclusion: In the assessment of pheochromocytoma, the combination of 18F-DOPA PET with MRI is superior to MRI-alone. 18F-DOPA PET/MRI may yield a higher diagnostic confidence for the detection of pheochromocytoma than 18F-DOPA PET/CT. ER -